Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: Stimulation of interleukin-8 secretion, potentiation of interleukin-1β effect and increase in the transepithelial passage of commensal bacteria

Toxicology and Applied Pharmacology

Volumn 228, Issue 1, 2008, Pages 84-92

  Maresca, Marc ^a   Yahi, Nouara ^a   Younès Sakr, Lama ^b   Boyron, Marilyn ^a   Caporiccio, Bertrand ^b   Fantini, Jacques ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Caco 2; Deoxynivalenol; Enteropathogenic mycotoxin; Interleukin 8; Intestinal inflammation; Ochratoxin A; Patulin

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 8; MYCOTOXIN; OCHRATOXIN; PATULIN; VOMITOXIN;

ARTICLE; BACTERIUM; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG EFFECT; ENTERITIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE EPITHELIUM; INTOXICATION;

BACTERIA; CACO-2 CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-8; INTESTINAL MUCOSA; MYCOTOXINS; NF-KAPPA B; OCHRATOXINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PATULIN; PERMEABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRICHOTHECENES;

ANIMALIA; ESCHERICHIA COLI;

EID: 40849101434     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.11.013     Document Type: Article

References (64)

1. Al-Anati L., and Petzinger E. Immunotoxic activity of ochratoxin A. J. Vet. Pharmacol. Ther. 29 (2006) 79-90
2. Al-Sadi R.M., and Ma T.Y. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 178 (2007) 4641-4649
3. Baggiolini M., Dewald B., and Moser B. Human chemokines: an update. Annu. Rev. Immunol. 15 (1997) 675-705
4. Bambou J.C., Giraud A., Menard S., Begue B., Rakotobe S., Heyman M., Taddei F., Cerf-Bensussan N., and Gaboriau-Routhiau V. In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J. Biol. Chem. 279 (2004) 42984-42992
5. Bennett J.W., and Klich M. Mycotoxins. Clin. Microbiol. Rev. 16 (2003) 497-516
6. Bondy G.S., and Pestka J.J. Immunomodulation by fungal toxins. J. Toxicol. Environ. Health, Part B. Crit. Rev. 3 (2000) 109-143
7. Boudeau J., Glasser A.L., Masseret E., Joly B., and Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect. Immun. 67 (1999) 4499-4509
8. Bouhet S., and Oswald I.P. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Vet. Immunol. Immunopathol. 108 (2005) 199-209
9. Bouhet S., LeDorze E., Peres S., Fairbrother J.M., and Oswald I.P. Mycotoxin fumonisin B1 selectively down-regulates the basal IL-8 expression in pig intestine: in vivo and in vitro studies. Food Chem. Toxicol. 44 (2006) 1768-1773
10. Bryden W.L. Mycotoxins in the food chain: human health implications. Asia Pac. J. Clin. Nutr. 16 (2007) 95-101
11. Campbell A.W., Thrasher J.D., Gray M.R., and Vojdani A. Mold and mycotoxins: effects on the neurological and immune systems in humans. Adv. Appl. Microbiol. 55 (2004) 375-406
12. Clark H.A., and Snedeker S.M. Ochratoxin A: its cancer risk and potential for exposure. J. Toxicol. Environ. Health, Part B. Crit. Rev. 9 (2006) 265-296
13. Clark E., Hoare C., Tanianis-Hughes J., Carlson G.L., and Warhurst G. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 128 (2005) 1258-1267
14. Fantini J., Yahi N., and Chermann J.C. Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 9297-9301
15. Frisvad J.C., Thrane U., Samson R.A., and Pitt J.I. Important mycotoxins and the fungi which produce them. Adv. Exp. Med. Biol. 571 (2006) 3-31
16. Fuchs R., and Peraica M. Ochratoxin A in human kidney diseases. Food Addit. Contam. 22 (2005) 53-57
17. Fukata T., Sasai K., Baba E., and Arakawa A. Effect of ochratoxin A on Salmonella typhimurium-challenged layer chickens. Avian Dis. 40 (1996) 924-926
18. Fung F., and Clark R.F. Health effects of mycotoxins: a toxicological overview. J. Toxicol., Clin. Toxicol. 42 (2004) 217-234
19. Garmy N., Taieb N., Yahi N., and Fantini J. Interaction of cholesterol with sphingosine: physicochemical characterization and impact on intestinal absorption. J. Lipid Res. 46 (2005) 36-45
20. Hunder G., Schumann K., Strugala G., Gropp J., Fichtl B., and Forth W. Influence of subchronic exposure to low dietary deoxynivalenol, a trichothecene mycotoxin, on intestinal absorption of nutrients in mice. Food Chem. Toxicol. 29 (1991) 809-814
21. Instanes C., and Hetland G. Deoxynivalenol (DON) is toxic to human colonic, lung and monocytic cell lines, but does not increase the IgE response in a mouse model for allergy. Toxicology 204 (2004) 13-21
22. Islam Z., and Pestka J.J. LPS priming potentiates and prolongs proinflammatory cytokine response to the trichothecene deoxynivalenol in the mouse. Toxicol. Appl. Pharmacol. 211 (2006) 53-63
23. Iwamoto G.K., Monick M.M., Burmeister L.F., and Hunninghake G.W. Interleukin 1 release by human alveolar macrophages and blood monocytes. Am. J. Physiol. 256 (1989) C1012-C1015
24. Kanisawa M., Suzuki S., Kozuka Y., and Yamazaki M. Histopathological studies on the toxicity of ochratoxin A in rats: I. Acute oral toxicity. Toxicol. Appl. Pharmacol. 42 (1977) 55-64
25. Kanisawa M., Suzuki S., and Moroi K. The mode of action of ochratoxin A in acute enteritis in rats. J. Environ. Pathol. Toxicol. Oncol. 10 (1990) 56-63
26. Kasuga F., Hara-Kudo Y., Saito N., Kulagai S., and Sugita-Konishi Y. In vitro effect of deoxynivalenol on the differentiation of human colonic cell lines Caco-2 and T84. Mycopathologia 142 (1998) 161-167
27. McKay D.M. Intestinal inflammation and the gut microflora. Can. J. Gastroenterol. 13 (1999) 509-516
28. McKinley E.R., and Carlton W.W. Patulin mycotoxicosis in Swiss ICR mice. Food Cosmet. Toxicol. 18 (1980) 181-187
29. McKinley E.R., and Carlton W.W. Patulin mycotoxicosis in the Syrian hamster. Food Cosmet. Toxicol. 18 (1980) 173-179
30. McKinley E.R., Carlton W.W., and Boon G.D. Patulin mycotoxicosis in the rat: toxicology, pathology and clinical pathology. Food Chem. Toxicol. 20 (1982) 289-300
31. Kleessen B., Kroesen A.J., Buhr H.J., and Blaut M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 37 (2002) 1034-1041
32. Kubena L.F., Phillips T.D., Witzel D.A., and Heidelbaugh N.D. Toxicity of ochratoxin A and penicillic acid to chicks. Bull. Environ. Contam. Toxicol. 32 (1984) 711-716
33. Lambert D., Padfield P.J., McLaughlin J., Cannell S., and O'Neill C.A. Ochratoxin A displaces claudins from detergent resistant membrane microdomains. Biochem. Biophys. Res. Commun. 358 (2007) 632-636
34. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) method. Methods 25 (2001) 402-408
35. Mahfoud R., Maresca M., Garmy N., and Fantini J. The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione. Toxicol. Appl. Pharmacol. 181 (2002) 209-218
36. Maresca M., Mahfoud R., Pfohl-Leszkowicz A., and Fantini J. The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. Toxicol. Appl. Pharmacol. 176 (2001) 54-63
37. Maresca M., Mahfoud R., Garmy N., and Fantini J. The mycotoxin deoxynivalenol affects nutrient absorption in human intestinal epithelial cells. J. Nutr. 132 (2002) 2723-2731
38. Martin H.M., Campbell B.J., Hart C.A., Mpofu C., Nayar M., Singh R., Englyst H., Williams H.F., and Rhodes J.M. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127 (2004) 80-93
39. Mbandi E., and Pestka J.J. Deoxynivalenol and satratoxin G potentiate proinflammatory cytokine and macrophage inhibitory protein 2 induction by Listeria and Salmonella in the macrophage. J. Food Prot. 69 (2006) 1334-1339
40. McLaughlin J., Padfield P.J., Burt J.P., and O'Neill C.A. Ochratoxin A increases permeability through tight junctions by removal of specific claudin isoforms. Am. J. Physiol., Cell Physiol. 287 (2004) C1412-C1417
41. Miller M.D., and Krangel M.S. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12 (1992) 17-46
42. Moon Y., Yang H., and Lee S.H. Modulation of early growth response gene 1 and interleukin-8 expression by ribotoxin deoxynivalenol (vomitoxin) via ERK1/2 in human epithelial intestine 407 cells. Biochem. Biophys. Res. Commun. 362 (2007) 256-262
43. Nazli A., Yang P.C., Jury J., Howe K., Watson J.L., Soderholm J.D., Sherman P.M., Perdue M.H., and McKay D.M. Epithelia under metabolic stress perceive commensal bacteria as a threat. Am. J. Pathol. 164 (2004) 947-957
44. Nazli A., Wang A., Steen O., Prescott D., Lu J., Perdue M.H., Soderholm J.D., Sherman P.M., and McKay D.M. Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia. Infect. Immun. 74 (2006) 192-201
45. Oswald I.P., Marin D.E., Bouhet S., Pinton P., Taranu I., and Accensi F. Immunotoxicological risk of mycotoxins for domestic animals. Food Addit. Contam. 22 (2005) 354-360
46. Osweiler G.D. Mycotoxins. Contemporary issues of food animal health and productivity. Vet. Clin. North Am., Food. Anim. Pract. 16 (2000) 511-530
47. Pestka J.J., Zhou H.R., Moon Y., and Chung Y.J. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol. Lett. 153 (2004) 61-73
48. Pfohl-Leszkowicz A., and Manderville R.A. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 51 (2007) 61-99
49. Pineiro M. Mycotoxins: natural toxins of agricultural and health significance. Forum Nutr. 56 (2003) 409-412
50. Pitt J.I., Basilico J.C., Abarca M.L., and Lopez C. Mycotoxins and toxigenic fungi. Med. Mycol. 38 (2000) 41-46
51. Purchase I.F., and Theron J.J. The acute toxicity of ochratoxin A to rats. Food Cosmet. Toxicol. 6 (1968) 479-483
52. Rotter B.A., Prelusky D.B., and Pestka J.J. Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. Environ. Health 48 (1996) 1-34
53. Ruchaud-Sparagano M.H., Maresca M., and Kenny B. Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell. Microbiol. 9 (2007) 1909-1921
54. Sasaki M., Sitaraman S.V., Babbin B.A., Gerner-Smidt P., Ribot E.M., Garrett N., Alpern J.A., Akyildiz A., Theiss A.L., Nusrat A., and Klapproth J.M. Invasive Escherichia coli are a feature of Crohn's disease. Lab. Invest. 87 (2007) 1042-1054
55. Schuerer-Maly C.C., Eckmann L., Kagnoff M.F., Falco M.T., and Maly F.E. Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology 81 (1994) 85-91
56. Sergent T., Parys M., Garsou S., Pussemier L., Schneider Y.J., and Larondelle Y. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol. Lett. 164 (2006) 167-176
57. Shibata Y., Nakamura H., Kato S., and Tomoike H. Cellular detachment and deformation induce IL-8 gene expression in human bronchial epithelial cells. J. Immunol. 156 (1996) 772-777
58. Speijers G.J., Franken M.A., and van Leeuwen F.X. Subacute toxicity study of patulin in the rat: effects on the kidney and the gastro-intestinal tract. Food Chem. Toxicol. 26 (1988) 23-30
59. Stark A.A. Threat assessment of mycotoxins as weapons: molecular mechanisms of acute toxicity. J. Food Prot. 68 (2005) 1285-1293
60. Swidsinski A., Ladhoff A., Pernthaler A., Swidsinski S., Loening-Baucke V., Ortner M., Weber J., Hoffmann U., Schreiber S., Dietel M., and Lochs H. Mucosal flora in inflammatory bowel disease. Gastroenterology 122 (2002) 44-54
61. Szczech G.M., Carlton W.W., Tuite J., and Caldwell R. Ochratoxin A toxicosis in swine. Vet. Pathol. 10 (1973) 347-364
62. Zhou H.R., Harkeme J.R., Yan D., and Pestka J.J. Amplified proinflammatory cytokine expression and toxicity in mice coexposed to lipopolysaccharide and the trichothecene vomitoxin (deoxynivalenol). J. Toxicol. Environ. Health, Part A 57 (1999) 115-136
63. Zhou H.R., Lau A.S., and Pestka J.J. Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response. Toxicol. Sci. 74 (2003) 335-344
64. Zhou X., Giron J.A., Torres A.G., Crawford J.A., Negrete E., Vogel S.N., and Kaper J.B. Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells. Infect. Immun. 71 (2003) 2120-2129